• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Boule Diagnostics

3.93 SEK

+0.77 %

Less than 1K followers

BOUL

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.77 %
+21.30 %
-0.76 %
-25.57 %
-19.96 %
-54.93 %
-63.81 %
-90.40 %
-57.31 %

Boule Diagnostics operates in the medical technology industry and focuses on the development and manufacture of diagnostic instruments for hematology. The company's products are aimed at healthcare institutions and laboratories. The business is global with a main presence in Europe, North America and Asia. Boule Diagnostics was founded in 1956 and is headquartered in Spånga, Sweden.

Read more
Market cap
152.61M SEK
Turnover
449.84K SEK
Revenue
489.6M
EBIT %
4.55 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7
2026

Interim report Q2'26

23.10
2026

Interim report Q3'26

10.2
2027

Annual report '26

Regulatory press release18.06.2026, 08.30

Boule Diagnostics appoints new Chief Executive Officer

Boule Diagnostics
Press release29.05.2026, 08.30

Interim CEO at Boule Diagnostics

Boule Diagnostics
Regulatory press release13.05.2026, 18.00

Bulletin from the Annual General Meeting May 13, 2026 in Boule Diagnostics

Boule Diagnostics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release28.04.2026, 08.00

Boule Diagnostics Interim Report Q1 2026

Boule Diagnostics
Press release27.04.2026, 17.00

Boule Diagnostics – Invitation to presentation of the interim report Q1 2026

Boule Diagnostics
Regulatory press release11.02.2026, 08.00

Boule Diagnostics Year-end report 2025

Boule Diagnostics
Press release06.02.2026, 10.30

Boule Diagnostics – Invitation to presentation of the Q4 report 2025

Boule Diagnostics
Press release21.01.2026, 08.30

Boule Diagnostics Renews and Expands a Global Supply Agreement

Boule Diagnostics
Regulatory press release30.12.2025, 08.30

Boule Diagnostics appoints Michael af Winklerfelt as new CFO

Boule Diagnostics
Press release22.12.2025, 11.00

Boule Diagnostics Selected as One of Three Providers in Nationwide Hematology Tender in Italy

Boule Diagnostics
Regulatory press release05.12.2025, 08.25

Boule Diagnostics Announces CEO Transition as Organization Prepares for Next Chapter

Boule Diagnostics
Regulatory press release21.11.2025, 16.00

Boule Diagnostics – Nomination Committee for the Annual General Meeting 2026

Boule Diagnostics
Regulatory press release24.10.2025, 08.00

Boule Diagnostics Interim Report Q3 2025

Boule Diagnostics
Press release20.10.2025, 10.45

Boule Diagnostics – Invitation to presentation of the interim report Q3 2025

Boule Diagnostics
Regulatory press release13.10.2025, 08.35

Boule Diagnostics Announces CFO Departure for New Opportunity

Boule Diagnostics
Regulatory press release18.07.2025, 08.00

Boule Diagnostics Interim Report Q2 2025

Boule Diagnostics
Press release11.07.2025, 11.00

Boule Diagnostics – Invitation to presentation of the interim report Q2 2025

Boule Diagnostics
Regulatory press release07.05.2025, 17.45

Bulletin from the Annual General Meeting May 7, 2025 in Boule Diagnostics

Boule Diagnostics
Regulatory press release28.04.2025, 08.00

Boule Diagnostics Interim Report Q1 2025

Boule Diagnostics
Press release23.04.2025, 13.00

Boule Diagnostics – Invitation to presentation of the interim report Q1 2025

Boule Diagnostics